Baidu
map

JCO:儿童癌症幸存者应如何规避未来的恶性肿瘤?

2017-05-26 MedSci MedSci原创

既往是研究发现儿童癌症幸存者(Childhood cancer survivors,CCS)随后的恶性肿瘤(subsequent malignant neoplasms,SMN)风险在增加。近来,研究人员在一个表征良好的5年CCS队列研究中评估了SMN的长期风险,研究特别关注了个体化疗药物和实体瘤风险。研究人员对荷兰儿童癌症肿瘤组儿童癌症队列后的长期影响进行了研究,共包括1963年-2001年在荷

既往是研究发现儿童癌症幸存者(Childhood cancer survivors,CCS)随后的恶性肿瘤(subsequent malignant neoplasms,SMN)风险在增加。近来,研究人员在一个表征良好的5年CCS队列研究中评估了SMN的长期风险,研究特别关注了个体化疗药物和实体瘤风险。

研究人员对荷兰儿童癌症肿瘤组儿童癌症队列后的长期影响进行了研究,共包括1963年-2001年在荷兰被确诊的6165例5年CCS。SMN通过荷兰癌症登记处,荷兰病理学注册表和医疗记录的审查被确定。研究人员计算了标准发病率、超额绝对风险和累计发生率。使用多变量Cox比例风险回归分析评估乳腺癌、肉瘤和所有实体瘤治疗相关风险。

首次确诊后平均随访20.7年(范围,5.0-49.8年)后,261例CCS患者中出现了291例SMN(标准化发病率,5.2;95%CI,4.6-5.8;超额绝对风险,20.3/万人-年)。首次确诊后25年的累计SMN发病率是3.9 %(95%CI,3.4%-4.6%),同时与治疗较早的患者相比,在1990年治疗的CCS患者中该数据没有显著变化。研究人员发现在所有实体瘤(p趋势<0.001)和乳腺癌(p趋势<0.001)中阿霉素相关的剂量依赖风险增加。乳腺癌的阿霉素剂量响应在李法美尼症候群(Li-Fraumeni syndrome,LFS,李-佛美尼综合症)相关的儿童癌症(白血病、CNS和非尤因肉瘤)幸存者中的强度大于其他癌症幸存者的(p差异 = 0.008)。此外,研究人员在剂量依赖研究中发现环磷酰胺增加肉瘤的风险(p趋势 =0.01)。

研究人员认为,该研究的结果强烈建议CCS患者的阿霉素暴露会增加随后的乳腺癌和实体瘤风险,然而,环磷酰胺暴露指挥增加肉瘤的风险。这些结果能对未来癌症儿童的治疗准则提供帮助,同时也有利于CCS的SMN监测指南。

原始出处:

Teepen JC, van Leeuwen FE,et al.Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.J Clin Oncol. 2017 May 22:JCO2016716902. doi: 10.1200/JCO.2016.71.6902. [Epub ahead of print]

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
    2017-11-09 lidong40
  2. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
    2017-06-05 laoli

    学习了,谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
    2017-05-28 ylzr123

    不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1891362, encodeId=31df18913623e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Thu Nov 09 18:45:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952356, encodeId=41e51952356e1, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Sun Sep 24 10:45:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=206658, encodeId=e43820665883, content=学习了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLC1BMzZWdMSPQWuib6BtQGicK8ygGBM6YakpfkRc67soFSuKbZr86enL1KggQZEZbgWSeicJibafmYfQ3AibicIHMwwicmDShfRFvvI38/0, createdBy=272a110164, createdName=laoli, createdTime=Mon Jun 05 06:42:40 CST 2017, time=2017-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438781, encodeId=3c4f1438e814c, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511113, encodeId=22a615111131a, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sun May 28 08:45:00 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=203457, encodeId=305520345e4b, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。给点个赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun May 28 07:10:20 CST 2017, time=2017-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202971, encodeId=42f82029e15e, content=学习了,不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/icyLhIGqru6gIknBJqfuPhQkEvDREF6S2vZq3ZIpUYjdqicKVoAWaJSGoe8xNvS6o6QpmOlh2AQ7xuUpj8NiaDjJJgjbc7Xj3T6/0, createdBy=1c242047915, createdName=daiyaozu, createdTime=Sat May 27 00:15:16 CST 2017, time=2017-05-27, status=1, ipAttribution=)]
    2017-05-27 daiyaozu

    学习了,不错

    0

相关资讯

纳米技术给药有望治疗儿童癌症

12月,分子药剂学报道了来自内穆尔为儿童癌症研究中心和特拉华大学材料科学与工程系的最新发现,这项发现是关于给予纳米技术化疗药的可能性的,通过这种方法可靶向破坏肿瘤细胞而不危害健康细胞。至目前为止,对以纳米粒子为基础的给药方法研究不很完善,,仅用于儿童白血病的治疗,其中包括30%的儿童期癌症患者。在内穆尔研究中,白血病的临床前模型中,与未服用地塞米松(DEX)胶囊的患者相比,服用DEX的患者的生活和

两篇NEJM:孩子为什么会得癌症

近年来,我们对儿童癌症的理解已经越来越深入。医生们现在面临的挑战是,如何更好的利用这些知识为患者提供治疗和指导。随着越来越多的儿童在癌症中幸存下来,这样的医学指导应当持续终生。孩子们为什么会得癌症?科学家们一直认为将基因视为这个问题的关键。顶级医学期刊《新英格兰医学》发表的一项最新研究表明,癌症患儿的癌症易感基因比人们想象的还要普遍。“即使家族史中没有出现过癌症,儿童也可能携带癌症易感基因,”费城

AIM:儿童癌症成年幸存者的心脏健康不容乐观

儿童癌症的成年幸存者中心脏疾病的研究一般都依赖于自我报告或基于注册表的数据。该研究的目的是为了系统地评估儿童癌症幸存者中心脏结果。该横断面研究在圣犹达儿童研究医院进行。共有1853名儿童癌症成年幸存者,年龄在18岁或以上,这些参与者都是早在至少10年以前就接受过癌症相关的心脏毒性治疗。干预措施包括基线病史和体检,空腹代谢和脂质检测,超声心动图,心电图,6分钟步行试验。幸存者的一半(52.3%)是男

ASCO 2015:黑色素瘤,口腔癌,脑转移癌以及儿童癌症的新近进展

2015年5月31日,芝加哥——第51届美国临床肿瘤学会(ASCO)会上提供了:关于儿童癌症生存期不积极治疗的影响;口腔癌手术的最佳时机;脑转移癌患者整个大脑辐射使用的长期的、结论性答案。另一项研究提供了针对黑色素瘤患者强有效的新免疫治疗选择。所有四项研究在ASCO的全体会议上发布,这些特征研究最可能影响患者的治疗。在美国,这些有望立即影响肿瘤治疗的临床实践的进展,将带来患者生存期和生活质量的改善

Lancet Oncology:2001 -2010年间国际儿童癌症发病率

研究者近日统计了过去的十年国际儿童癌症发病率

JCO:高血压可增加儿童癌症幸存者主要心血管事件风险

研究要点: 1.本研究发现可控心血管风险因素,尤其是高血压增强了与治疗相关的主要心血管事件风险;高血压为心血管死亡风险的独立相关因素。 2.胸部放疗及高血压的联合效应可增强各主要心血管事件的风险。 在2013年9月3日在线出版的《临床肿瘤学杂志》(Journal of ClinicalOncology)上,发表了美国圣裘德儿童研究医院Gregory T.Armstrong博士等人的一项研究结

Baidu
map
Baidu
map
Baidu
map